Literature DB >> 11463593

Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.

M D Eisner1, T Thompson, L D Hudson, J M Luce, D Hayden, D Schoenfeld, M A Matthay.   

Abstract

In patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), a recent ARDS Network randomized controlled trial demonstrated that a low tidal volume (VT) mechanical ventilation strategy (6 ml/kg) reduced mortality by 22% compared with traditional mechanical ventilation (12 ml/kg). In this study, we examined the relative efficacy of low VT mechanical ventilation among 902 patients with different clinical risk factors for ALI/ARDS who participated in ARDS Network randomized controlled trials. The clinical risk factor for ALI/ARDS was associated with substantial variation in mortality. The risk of death (before discharge home with unassisted breathing) was highest in patients with sepsis (43%); intermediate in subjects with pneumonia (36%), aspiration (37%), and other risk factors (35%); and lowest in those with trauma (11%) (p < 0.0001). Despite these differences in mortality, there was no evidence that the efficacy of the low VT strategy varied by clinical risk factor (p = 0.76, for interaction between ventilator group and risk factor). There was also no evidence of differential efficacy of low VT ventilation in the other study outcomes: proportion of patients achieving unassisted breathing (p = 0.59), ventilator-free days (p = 0.58), or development of nonpulmonary organ failure (p = 0.44). Controlling for demographic and clinical covariates did not appreciably affect these results. After reclassifying the clinical risk factors as pulmonary versus nonpulmonary predisposing conditions and infection-related versus non-infection-related conditions, there was still no evidence that the efficacy of low VT ventilation differed among clinical risk factor subgroups. In conclusion, we found no evidence that the efficacy of the low VT ventilation strategy differed among clinical risk factor subgroups for ALI/ARDS.

Entities:  

Mesh:

Year:  2001        PMID: 11463593     DOI: 10.1164/ajrccm.164.2.2011093

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  87 in total

1.  Health status after critical illness: beyond descriptive studies.

Authors:  Gordon D Rubenfeld; J Randall Curtis
Journal:  Intensive Care Med       Date:  2003-10       Impact factor: 17.440

2.  Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.

Authors:  Chau-Chyun Sheu; Michelle N Gong; Rihong Zhai; Feng Chen; Ednan K Bajwa; Peter F Clardy; Diana C Gallagher; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

Review 3.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

4.  Sequence of endothelial signaling during lung expansion.

Authors:  Maimaiti T Yiming; Kaushik Parthasarathi; Andrew C Issekutz; Sunita Bhattacharya
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-25       Impact factor: 6.914

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

6.  Acute respiratory distress syndrome: new definition, current and future therapeutic options.

Authors:  Vito Fanelli; Aikaterini Vlachou; Shirin Ghannadian; Umberto Simonetti; Arthur S Slutsky; Haibo Zhang
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

7.  Relationship of acute lung inflammatory injury to Fas/FasL system.

Authors:  Thomas A Neff; Ren-Feng Guo; Simona B Neff; J Vidya Sarma; Cecilia L Speyer; Hongwei Gao; Kurt D Bernacki; Markus Huber-Lang; Stephanie McGuire; L Marco Hoesel; Niels C Riedemann; Beatrice Beck-Schimmer; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Characteristics and outcomes of patients hospitalized following pulmonary aspiration.

Authors:  Augustine Lee; Emir Festic; Pauline K Park; Krishnan Raghavendran; Ousama Dabbagh; Adebola Adesanya; Ognjen Gajic; Raquel R Bartz
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

9.  Ventilatory strategies in patients with sepsis and respiratory failure.

Authors:  Dean R Hess; B Taylor Thompson
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

10.  Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.

Authors:  C S Calfee; L B Ware; M D Eisner; P E Parsons; B T Thompson; N Wickersham; M A Matthay
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.